Skip to main content
. 2019 Dec 11;10(1):106–113. doi: 10.15171/apb.2020.013

Table 1. Characteristics of the BC patients (n = 88) .

Variable Category No. (%)
Age (y) ≤ 50 45 (51.1)
> 50 43 (48.9)
BMI (kg/m2) <25 46 (52.3)
25-29.99 28 (31.8)
≥30 14 (15.9)
Pathologic grade I 21 (23.9)
II, III 67 (76.1)
Clinical stage I 66 (75)
II 14 (15.9)
III 8 (9.1)
Tumor size (cm) < 2.5 46 (52.3)
≥ 2.5 42 (47.7)
Tumor side status Right side 34 (38.6)
Left side 54 (61.4)
Lymph node metastasis N1 64 (72.7)
N2 13 (14.8)
N3 11 (12.5)
Estrogen receptor status Negative 43 (48.9)
Positive 45 (51.1)
Progesterone receptor status Negative 58 (65.9)
Positive 30 (34.1)
Her-2/neu receptor status Negative 61 (69.3)
Positive 27 (30.7)
P53 Negative 66 (75)
Positive 22 (25)